Nasdaq [NDAQ] vs CME [CME] Detailed Stock Comparison

Nasdaq, Inc.

NASDAQ
Loading...

CME Group Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Nasdaq, Inc. wins in 6 metrics, CME Group Inc. wins in 14 metrics, with 0 ties. CME Group Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Nasdaq, Inc. CME Group Inc. Better
P/E Ratio (TTM) 28.35 24.34 CME Group Inc.
Price-to-Book Ratio 4.08 3.57 CME Group Inc.
Debt-to-Equity Ratio 77.88 12.86 CME Group Inc.
PEG Ratio 0.61 1.03 Nasdaq, Inc.
EV/EBITDA 18.84 21.55 Nasdaq, Inc.
Profit Margin (TTM) 34.06% 63.31% CME Group Inc.
Operating Margin (TTM) 47.56% 69.66% CME Group Inc.
EBITDA Margin (TTM) 47.56% 69.66% CME Group Inc.
Return on Equity 15.25% 15.92% CME Group Inc.
Return on Assets (TTM) 5.06% 1.55% Nasdaq, Inc.
Free Cash Flow (TTM) $1.99B $4.19B CME Group Inc.
Dividend Yield 1.36% 4.11% CME Group Inc.
1-Year Return 3.96% 0.01% Nasdaq, Inc.
Price-to-Sales Ratio (TTM) 9.53 15.36 Nasdaq, Inc.
Enterprise Value $58.71B $103.28B CME Group Inc.
EV/Revenue Ratio 11.19 15.31 Nasdaq, Inc.
Gross Profit Margin (TTM) 44.35% N/A N/A
Revenue per Share (TTM) $9 $19 CME Group Inc.
Earnings per Share (Diluted) $3.09 $11.73 CME Group Inc.
Beta (Stock Volatility) 1.02 0.30 CME Group Inc.
Short % of Float 1.62% 1.44% CME Group Inc.

Nasdaq, Inc. vs CME Group Inc. Stock Performance Analysis

Loading Price Chart...

NDAQ
CME

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nasdaq, Inc.2.32%4.91%-0.02%6.05%-2.03%-5.81%
CME Group Inc.-1.28%5.57%-10.97%-15.22%-2.24%-1.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nasdaq, Inc.3.96%73.72%51.84%317.94%1,023.48%895.30%
CME Group Inc.0.01%46.40%27.92%186.46%384.94%196.68%

Performance & Financial Health Analysis: Nasdaq, Inc. vs CME Group Inc.

MetricNDAQCME
Market Information
Market Cap i$49.70B$103.42B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i3,072,8532,489,654
90 Day Avg. Volume i2,967,5212,270,221
Last Close$91.04$266.08
52 Week Range$77.09 - $101.79$244.56 - $329.16
% from 52W High-10.56%-19.16%
All-Time High$101.79 (Jan 16, 2026)$329.16 (Mar 03, 2026)
% from All-Time High-10.56%-19.16%
Growth Metrics
Quarterly Revenue Growth0.13%0.15%
Quarterly Earnings Growth0.46%0.21%
Financial Health
Profit Margin (TTM) i0.34%0.63%
Operating Margin (TTM) i0.48%0.70%
Return on Equity (TTM) i0.15%0.16%
Debt to Equity (MRQ) i77.8812.86
Cash & Liquidity
Book Value per Share (MRQ)$21.46$80.03
Cash per Share (MRQ)$1.08$7.56
Operating Cash Flow (TTM) i$2.26B$4.54B
Levered Free Cash Flow (TTM) i$1.67B$4.11B
Dividends
Last 12-Month Dividend Yield i1.36%4.11%
Last 12-Month Dividend i$1.32$12.45

Valuation & Enterprise Metrics Analysis: Nasdaq, Inc. vs CME Group Inc.

MetricNDAQ (Apr 24, 2026)CME (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i28.3524.34
Forward P/E i19.9422.14
PEG Ratio i0.611.03
Price to Sales (TTM) i9.5315.36
Price to Book (MRQ) i4.083.57
Market Capitalization
Market Capitalization i$49.70B$103.42B
Enterprise Value i$58.71B$103.28B
Enterprise Value Metrics
Enterprise to Revenue i11.1915.31
Enterprise to EBITDA i18.8421.55
Risk & Other Metrics
Beta i1.020.30
Book Value per Share (MRQ) i$21.46$80.03

Financial Statements Comparison: Nasdaq, Inc. vs CME Group Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNDAQ (2025)CME (2025)
Revenue/Sales i8.26B6.52B
Cost of Goods Sold i4.77B907.00M
COGS % of Revenue i57.8%13.9%
Gross Profit i3.49B5.61B
Gross Margin i42.2%86.1%
Research & Development iN/AN/A
Operating Income (EBIT) i2.43B4.23B
Operating Margin i29.4%64.9%
EBITDA i3.15B98.30M
EBITDA Margin i38.1%1.5%
Pre-Tax Income i2.15B5.33B
Pre-Tax Income % of Revenue i26.0%81.7%
Income Tax i358.00M1.26B
Income Tax % of Revenue i4.3%19.3%
Net Income (Profit) i1.79B4.07B
Profit Margin i21.6%62.5%

Balance Sheet & Liquidity Metrics

MetricNDAQ (2025)CME (2025)
Cash & Equivalents i604.00M4.42B
Total Current Assets i8.00B165.36B
Total Current Assets % of Revenue i96.9%2,536.0%
Total Current Liabilities i7.96B160.30B
Total Current Liabilities % of Revenue i96.4%2,458.3%
Long-Term Debt i9.04B3.42B
Long-Term Debt % of Revenue i109.4%52.5%
Total Shareholders Equity i12.23B28.73B
Retained Earnings i9.59B6.43B
Retained Earnings % of Revenue i116.0%98.7%
Property, Plant & Equipment i447.00M0

Cash Flow Statement Comparison

MetricNDAQ (2025)CME (2025)
Operating Cash Flow i2.71B4.54B
Operating Cash Flow % of Revenue i32.8%69.6%
Capital Expenditures i-266.00M-83.50M
Free Cash Flow i1.99B4.19B
FCF Margin i24.1%64.3%
Debt Repayment i-826.00M-750.00M
Common Stock Repurchase i-616.00M-266.10M

Short Interest & Institutional Ownership Analysis

MetricNDAQCME
Shares Short i7.29M4.70M
Short Ratio i2.382.28
Short % of Float i1.62%1.44%
Shares Outstanding i569.89M362.80M
Float Shares i505.91M357.72M
% Held by Insiders i10.86%0.48%
% Held by Institutions i86.98%91.89%
% Held by Public i2.16%7.63%

Dividend Analysis & Yield Comparison: Nasdaq, Inc. vs CME Group Inc.

MetricNDAQCME
Last 12-Month Dividend i$1.32$12.45
Last 12-Month Dividend Yield i1.36%4.11%
3-Year Avg Annual Dividend i$1.04$10.83
3-Year Avg Dividend Yield i0.35%0.92%
3-Year Total Dividends i$3.12$32.50
Ex-Dividend DateMar 16, 2026Mar 10, 2026